Latest news
Inmune Bio, Inc. Q2 2026: Revenue $0 Net loss $(1.27)M, EPS $(0.05) — 10-Q Summary - TradingViewTradingView · Thu, 06 Aug 2026 20:11:01 GMTExousia Bio Nearing Completion of Milestone Multimillion-Dollar Capital Investment - Yahoo FinanceYahoo Finance · Tue, 04 Aug 2026 14:59:00 GMTPeople on the Move: Jason Moore Joins Uniquity Bio as Senior Vice President, Regulatory & Quality - BioBuzzBioBuzz · Fri, 31 Jul 2026 17:18:06 GMT